Impact of Intercurrent Introduction of Steroids on Clinical Outcomes in Advanced Non-Small-Cell Lung Cancer (NSCLC) Patients under Immune-Checkpoint Inhibitors (ICI).
De Giglio A, Mezquita L, Auclin E, Blanc-Durand F, Riudavets M, Caramella C, Martinez G, Benitez JC, Martín-Romano P, El-Amarti L, Hendriks L, Ferrara R, Naltet C, Lavaud P, Gazzah A, Adam J, Planchard D, Chaput N, Besse B.
De Giglio A, et al. Among authors: besse b.
Cancers (Basel). 2020 Sep 30;12(10):2827. doi: 10.3390/cancers12102827.
Cancers (Basel). 2020.
PMID: 33007977
Free PMC article.